Annual ROE
-45.21%
-13.33%-41.81%
December 31, 2023
Summary
- As of February 7, 2025, LRMR annual return on equity is -45.21%, with the most recent change of -13.33% (-41.81%) on December 31, 2023.
- During the last 3 years, LRMR annual ROE has risen by +2.15% (+4.54%).
- LRMR annual ROE is now -101.36% below its all-time high of 3333.14%, reached on December 31, 2019.
Performance
LRMR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-35.87%
+1.97%+5.21%
September 30, 2024
Summary
- As of February 7, 2025, LRMR quarterly return on equity is -35.87%, with the most recent change of +1.97% (+5.21%) on September 30, 2024.
- Over the past year, LRMR quarterly ROE has increased by +1.97% (+5.21%).
- LRMR quarterly ROE is now -100.99% below its all-time high of 3614.12%, reached on March 31, 2020.
Performance
LRMR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LRMR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.8% | +5.2% |
| 3 y3 years | +4.5% | +5.2% |
| 5 y5 years | -101.4% | +5.2% |
LRMR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.8% | +42.5% | -19.7% | +50.7% |
| 5 y | 5-year | -101.4% | +42.5% | -101.0% | +50.7% |
| alltime | all time | -101.4% | +42.5% | -101.0% | +50.7% |
Larimar Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -35.87%(-5.2%) |
| Jun 2024 | - | -37.84%(+6.0%) |
| Mar 2024 | - | -35.69%(-8.1%) |
| Dec 2023 | -45.21%(+41.8%) | -38.83%(+19.2%) |
| Sep 2023 | - | -32.58%(+8.7%) |
| Jun 2023 | - | -29.96%(-12.2%) |
| Mar 2023 | - | -34.14%(-18.7%) |
| Dec 2022 | -31.88% | -42.00%(-13.1%) |
| Sep 2022 | - | -48.32%(-32.4%) |
| Jun 2022 | - | -71.50%(-1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -72.75%(+1.6%) |
| Dec 2021 | -78.61%(+66.0%) | -71.62%(-1.0%) |
| Sep 2021 | - | -72.33%(+24.5%) |
| Jun 2021 | - | -58.08%(+16.3%) |
| Mar 2021 | - | -49.94%(+19.5%) |
| Dec 2020 | -47.36%(-101.4%) | -41.80%(-13.0%) |
| Sep 2020 | - | -48.05%(-17.8%) |
| Jun 2020 | - | -58.49%(-101.6%) |
| Mar 2020 | - | 3614.12%(+36.3%) |
| Dec 2019 | 3333.14% | 2652.45% |
FAQ
- What is Larimar Therapeutics annual return on equity?
- What is the all time high annual ROE for Larimar Therapeutics?
- What is Larimar Therapeutics annual ROE year-on-year change?
- What is Larimar Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly ROE year-on-year change?
What is Larimar Therapeutics annual return on equity?
The current annual ROE of LRMR is -45.21%
What is the all time high annual ROE for Larimar Therapeutics?
Larimar Therapeutics all-time high annual return on equity is 3333.14%
What is Larimar Therapeutics annual ROE year-on-year change?
Over the past year, LRMR annual return on equity has changed by -13.33% (-41.81%)
What is Larimar Therapeutics quarterly return on equity?
The current quarterly ROE of LRMR is -35.87%
What is the all time high quarterly ROE for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly return on equity is 3614.12%
What is Larimar Therapeutics quarterly ROE year-on-year change?
Over the past year, LRMR quarterly return on equity has changed by +1.97% (+5.21%)